Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6000)
All Articles published online
|
Mar 7, 2013 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | López-Serrano P, Pérez-Calle JL, Sánchez-Tembleque MD. Hepatitis B and inflammatory bowel disease: Role of antiviral prophylaxis. World J Gastroenterol 2013; 19(9): 1342-1348 [PMID: 23538480 DOI: 10.3748/wjg.v19.i9.1342] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i9/1342.htm |
| Number | Citing Articles |
| 1 |
Michelle C.M. Cheung, Kosh Agarwal. Liver abnormalities in the immunosuppressed. Best Practice & Research Clinical Gastroenterology 2013; 27(4): 597 doi: 10.1016/j.bpg.2013.06.017
|
| 2 |
Rupert W. Leong, Anthony Sakiris, Arteen Arzivian, John David Chetwood, Thanaboon Chaemsupaphan, Miles P. Sparrow, Michael A. Kamm, Viraj Kariayawasam. Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases. Alimentary Pharmacology & Therapeutics 2024; doi: 10.1111/apt.18318
|
| 3 |
Ruwaida Ben Musa, Anuhya Gampa, Sanjib Basu, Ali Keshavarzian, Garth Swanson, Michael Brown, Rana Abraham, Keith Bruninga, John Losurdo, Mark DeMeo, Sohrab Mobarhan, David Shapiro, Ece Mutlu. Hepatitis B vaccination in patients with inflammatory bowel disease. World Journal of Gastroenterology 2014; 20(41): 15358-15366 doi: 10.3748/wjg.v20.i41.15358
|
| 4 |
S. K. Sarin, M. Kumar, G. K. Lau, Z. Abbas, H. L. Y. Chan, C. J. Chen, D. S. Chen, H. L. Chen, P. J. Chen, R. N. Chien, A. K. Dokmeci, Ed Gane, J. L. Hou, W. Jafri, J. Jia, J. H. Kim, C. L. Lai, H. C. Lee, S. G. Lim, C. J. Liu, S. Locarnini, M. Al Mahtab, R. Mohamed, M. Omata, J. Park, T. Piratvisuth, B. C. Sharma, J. Sollano, F. S. Wang, L. Wei, M. F. Yuen, S. S. Zheng, J. H. Kao. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatology International 2016; 10(1): 1 doi: 10.1007/s12072-015-9675-4
|
| 5 |
Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng. IBD barriers across the continents – East Asia. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231212089
|
| 6 |
Evidence‐based consensus on opportunistic infections in inflammatory bowel disease. Journal of Digestive Diseases 2018; 19(2): 54 doi: 10.1111/1751-2980.12578
|
| 7 |
Juozas Grigas, Maria Montoya, Evelina Simkute, Marius Buitkus, Ruta Zagrabskaite, Arnoldas Pautienius, Dainius Razukevicius, Laimas Virginijus Jonaitis, Gediminas Kiudelis, Jurgita Skieceviciene, Ruta Vaiciuniene, Asta Stankuviene, Inga Arune Bumblyte, Juozas Kupcinskas, Arunas Stankevicius. Molecular Characterization and Seroprevalence of Hepatitis E Virus in Inflammatory Bowel Disease Patients and Solid Organ Transplant Recipients. Viruses 2021; 13(4): 670 doi: 10.3390/v13040670
|
| 8 |
Jing Fang, Wenge Li, Xiangxin Peng, Zhao Tan, Min Tan, Cong Zhang, Wenbo Wang, Zhihong Xu, Gumin Zhou. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis. International Urology and Nephrology 2017; 49(3): 475 doi: 10.1007/s11255-016-1487-5
|
| 9 |
Jing Fang, Wenge Li, Min Tan, Xiangxin Peng, Zhao Tan, Wenbo Wang. Effect of different hepatitis B infection status on the prognosis of active lupus nephritis treated with immunosuppression: a retrospective analysis of 177 patients. International Journal of Rheumatic Diseases 2018; 21(5): 1060 doi: 10.1111/1756-185X.13313
|
| 10 |
Claudio Bonifati, Viviana Lora, Dario Graceffa, Lorenzo Nosotti. Management of psoriasis patients with hepatitis B or hepatitis C virus infection. World Journal of Gastroenterology 2016; 22(28): 6444-6455 doi: 10.3748/wjg.v22.i28.6444
|
| 11 |
Vlad Alexandru Ionescu, Gina Gheorghe, Valentin Nicolae Varlas, Ana Maria Alexandra Stanescu, Camelia Cristina Diaconu. Hepatobiliary Impairments in Patients with Inflammatory Bowel Diseases: The Current Approach. Gastroenterology Insights 2022; 14(1): 13 doi: 10.3390/gastroent14010002
|
| 12 |
Miguel Cordero-Coma, Raquel Salazar-Méndez, Taygan Yilmaz. Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues. Expert Opinion on Drug Safety 2015; 14(9): 1353 doi: 10.1517/14740338.2015.1061992
|
| 13 |
Kazuyuki Suzuki, Ichiro Kumagai, Yuichi Yoshida, Akio Miyasaka, Yasuhiro Takikawa, Ryoichi Kamiya, Kouryo Kondo, Akinobu Kato, Toshimi Chiba, Hiroaki Okamoto. Asymptomatic acute hepatitis E in a female patient with ulcerative colitis. Clinical Journal of Gastroenterology 2017; 10(3): 255 doi: 10.1007/s12328-017-0730-7
|
| 14 |
Marisa E. Luck, Stefan A. Muljo, Colm B. Collins. Prospects for Therapeutic Targeting of MicroRNAs in Human Immunological Diseases. The Journal of Immunology 2015; 194(11): 5047 doi: 10.4049/jimmunol.1403146
|
| 15 |
J.K. Yamamoto-Furusho, F. Bosques-Padilla, P. Daffra, J.A. De Paula, J. Etchevers, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.M. Marroquín de la Garza, R. Monreal Robles, J.L. Rocha, F. Steinwurz, R. Vázquez-Frías, G. Veitia, C. Zaltman. Situaciones especiales en la enfermedad inflamatoria intestinal: primer consenso latinoamericano de la Pan American Crohn's and Colitis Organisation (PANCCO) (Segunda parte). Revista de Gastroenterología de México 2017; 82(2): 134 doi: 10.1016/j.rgmx.2016.07.005
|
| 16 |
Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication). Intestinal Research 2018; 16(2): 178 doi: 10.5217/ir.2018.16.2.178
|
| 17 |
Ji Young Chang, Sung-Ae Jung, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim. Response to hepatitis B vaccination in patients with inflammatory bowel disease: a prospective observational study in Korea. Intestinal Research 2018; 16(4): 599 doi: 10.5217/ir.2018.00012
|
| 18 |
Douglas L. Nguyen, Emily T. Nguyen, Matthew L. Bechtold. Effect of Immunosuppressive Therapies for the Treatment of Inflammatory Bowel Disease on Response to Routine Vaccinations: A Meta-Analysis. Digestive Diseases and Sciences 2015; 60(8): 2446 doi: 10.1007/s10620-015-3631-y
|
| 19 |
Pilar López-Serrano, Elsa de la Fuente Briongos, Elisa Carrera Alonso, Jose Lázaro Pérez-Calle, Conrado Fernández Rodríguez. Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy. World Journal of Hepatology 2015; 7(3): 539-547 doi: 10.4254/wjh.v7.i3.539
|
| 20 |
Adérson Omar Mourão Cintra Damião. A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy. Medical Science Monitor 2014; 20: 487 doi: 10.12659/MSM.890331
|
| 21 |
Carlos Walter Sobrado, Natália Sousa Freitas Queiroz, Caio Almeida Perez. Biological Therapy for Inflammatory Bowel Disease. 2020; doi: 10.5772/intechopen.90204
|
| 22 |
Leilei Zhu, Gil Y. Melmed. Treatment of Inflammatory Bowel Disease with Biologics. 2018; : 315 doi: 10.1007/978-3-319-60276-9_18
|
| 23 |
Luigi Marongiu, Sascha Venturelli, Heike Allgayer. Involvement of HHV-4 (Epstein–Barr Virus) and HHV-5 (Cytomegalovirus) in Inflammatory Bowel Disease and Colorectal Cancer: A Meta-Analysis. Cancers 2022; 14(20): 5085 doi: 10.3390/cancers14205085
|
| 24 |
Mohammad Shehab, Fatema Alrashed, Munerah Alyaseen, Zainab Safar, Tunrayo Adekunle, Ahmad Alfadhli, Talat Bessissow. Immunogenicity of Hepatitis B Vaccination in Patients with Ulcerative Colitis on Infliximab Is Attenuated Compared to Those on 5-Aminosalicylic Acid Therapies: A Prospective Observational Study. Vaccines 2024; 12(4): 364 doi: 10.3390/vaccines12040364
|
| 25 |
Jing Fang, Wenge Li, Min Tan, Wen Chen, Cong Zhang, Wenbo Wang, Qianqian Xu, Xinzhen Guo. Discontinuation of antiviral prophylaxis increased the risk of hepatitis B virus reactivation in glomerulonephritis patients under immunotherapy: a real-life observation. International Urology and Nephrology 2018; 50(9): 1653 doi: 10.1007/s11255-018-1867-0
|
| 26 |
J.K. Yamamoto-Furusho, F. Bosques-Padilla, P. Daffra, J.A. De Paula, J. Etchevers, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.M. Marroquín de la Garza, R. Monreal Robles, J.L. Rocha, F. Steinwurz, R. Vázquez-Frías, G. Veitia, C. Zaltman. Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part). Revista de Gastroenterología de México (English Edition) 2017; 82(2): 134 doi: 10.1016/j.rgmxen.2016.07.004
|